How items are ranked
- Evidence level: regulatory action and guidelines, then phase 3 RCT, meta-analysis, prospective, retrospective, commentary.
- Source tier: peer-reviewed journal and regulator first, then society and trade press.
- Practice impact: whether it changes what a provider can offer this month.
Ranking is rule-based. No sponsor or author pays for placement.
Editorial policy
UrologyWatch is a neutral aggregator. Summaries are original and link to the primary source; we do not reproduce abstracts or figures. A new edition is published every morning at about 5 AM ET; the time at the top of the page shows when the current edition was built.
Archive by date · About UrologyWatch · Urology History
Daily email
Not medical advice
Content is for general information. Patients should discuss any treatment decision with their own urology provider.
Privacy · Terms of use
© 2026 UrologyWatch.com